StonvexLoading…
StonvexStonvexStonvexCore line items from LII's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.57B | $1.14B | $5.20B | $1.43B | $1.50B |
Operating Income | Not available | $163.50M | $1.04B | $328.80M | $349.00M |
Net Income | Not available | $117.20M | $805.80M | $259.90M | $273.90M |
EPS (Diluted) | $7.66 | $3.35 | $22.79 | $7.38 | $7.71 |
Total Assets | Not available | $4.29B | $4.08B | $3.52B | $3.65B |
Total Liabilities | Not available | $3.08B | $2.92B | $2.45B | $2.75B |
Cash & Equivalents | Not available | $48.20M | $34.20M | $52.90M | $49.20M |
Free Cash Flow OCF − CapEx | Not available | $-39.40M | $638.80M | $262.10M | $-3.00M |
Shares Outstanding | Not available | 35.00M | 35.40M | 35.50M | 35.60M |